Bone Health Determinants in Ambulant Prepubertal Boys With Duchenne Muscular Dystrophy Treated With Deflazacort: Findings From a 3‐Year Study

Documenti analoghi

• Anaphylaxis During Delandistrogene Moxeparvovec Infusion Therapy in a Boy With Duchenne Muscular Dystrophy
  di: Regina Laine, et al.
  Pubblicazione: (2025)
• Prophylactic Use of Cardiac Medications and Survival in Duchenne Muscular Dystrophy
  di: Kristin M. Conway, et al.
  Pubblicazione: (2025)
• Incidence of Radiologically Confirmed Fractures in Adults With Duchenne Muscular Dystrophy
  di: Gavin Langlands, et al.
  Pubblicazione: (2025)
• Serum Creatine Kinase and Transaminase Levels in Duchenne and Becker Muscular Dystrophies
  di: Marie Rohlenová, et al.
  Pubblicazione: (2025)
• Asynchrony Related to Mechanical Ventilation Exacerbates Diaphragm Dysfunction in a Mouse Model of Duchenne Muscular Dystrophy
  di: Mohamad Yehya, et al.
  Pubblicazione: (2026)